Asia · Regional markets · CNBC-TV18

Piramal Pharma shares surge 14% as Q2 profitability improves, FY27 outlook raised

Published by CNBC-TV18 · India 1 h ago

Following its strong first-half performance and sustained business momentum, Piramal Pharma upgraded its FY27 revenue growth outlook to 19%-20%. The company also expects…

Read the full article on CNBC-TV18 Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

Tech in Asia

Mirae Asset taps Solana for HK institutional note issuance

Mint

Stock market crash today: Sensex plunges 995 points, Nifty sheds 1% ahead of Fed decision: Here's what spooked D-Street

The Business Times

Piramal Pharma shares surge 14% as Q2 profitability improves, FY27 outlook raised

Share

Also worth reading

Mirae Asset taps Solana for HK institutional note issuance

Stock market crash today: Sensex plunges 995 points, Nifty sheds 1% ahead of Fed decision: Here's what spooked D-Street

SingPost to streamline EU-bound shipments under new customs rules from Nov 1

Ambani’s Jio surges 21% in Mumbai debut after record $3.2 billion India IPO

Pakistan decides to tighten its AML-CFT regimes

China's DeepSeek Ranks First in Call Volume on OpenRouter for Third Straight Week